Intervention

Supine MRI

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

3 shown

21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI TrialNCT05131607 · 2022-03-17

UNKNOWN

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant TherapyNCT02956473 · 2016-11-15

COMPLETED

A Study to Evaluate the Use of Supine MRI Images in Breast Conserving SurgeryNCT01929395 · 2009-09-01

COMPLETED

Common conditions

Breast Cancer2 Breast Cancer Female1

Leading sponsors

Dartmouth-Hitchcock Medical Center2 Dana-Farber Cancer Institute1

Trial status mix

COMPLETED2

UNKNOWN1

Phase mix

NA3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.